Cargando…
PB1879: OVERALL SURVIVAL OF RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH IBRUTINIB IN ALBANIA (2018-2022)
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431682/ http://dx.doi.org/10.1097/01.HS9.0000850368.90532.f1 |
| _version_ | 1784780122326302720 |
|---|---|
| author | Calliku, E. Perolla, A. Cili, A. Pulluqi, P. Caja, T. Ivanaj, A. |
| author_facet | Calliku, E. Perolla, A. Cili, A. Pulluqi, P. Caja, T. Ivanaj, A. |
| author_sort | Calliku, E. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431682 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94316822022-08-31 PB1879: OVERALL SURVIVAL OF RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH IBRUTINIB IN ALBANIA (2018-2022) Calliku, E. Perolla, A. Cili, A. Pulluqi, P. Caja, T. Ivanaj, A. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431682/ http://dx.doi.org/10.1097/01.HS9.0000850368.90532.f1 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Calliku, E. Perolla, A. Cili, A. Pulluqi, P. Caja, T. Ivanaj, A. PB1879: OVERALL SURVIVAL OF RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH IBRUTINIB IN ALBANIA (2018-2022) |
| title | PB1879: OVERALL SURVIVAL OF RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH IBRUTINIB IN ALBANIA (2018-2022) |
| title_full | PB1879: OVERALL SURVIVAL OF RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH IBRUTINIB IN ALBANIA (2018-2022) |
| title_fullStr | PB1879: OVERALL SURVIVAL OF RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH IBRUTINIB IN ALBANIA (2018-2022) |
| title_full_unstemmed | PB1879: OVERALL SURVIVAL OF RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH IBRUTINIB IN ALBANIA (2018-2022) |
| title_short | PB1879: OVERALL SURVIVAL OF RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH IBRUTINIB IN ALBANIA (2018-2022) |
| title_sort | pb1879: overall survival of relapsed/refractory chronic lymphocytic leukemia patients treated with ibrutinib in albania (2018-2022) |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431682/ http://dx.doi.org/10.1097/01.HS9.0000850368.90532.f1 |
| work_keys_str_mv | AT callikue pb1879overallsurvivalofrelapsedrefractorychroniclymphocyticleukemiapatientstreatedwithibrutinibinalbania20182022 AT perollaa pb1879overallsurvivalofrelapsedrefractorychroniclymphocyticleukemiapatientstreatedwithibrutinibinalbania20182022 AT cilia pb1879overallsurvivalofrelapsedrefractorychroniclymphocyticleukemiapatientstreatedwithibrutinibinalbania20182022 AT pulluqip pb1879overallsurvivalofrelapsedrefractorychroniclymphocyticleukemiapatientstreatedwithibrutinibinalbania20182022 AT cajat pb1879overallsurvivalofrelapsedrefractorychroniclymphocyticleukemiapatientstreatedwithibrutinibinalbania20182022 AT ivanaja pb1879overallsurvivalofrelapsedrefractorychroniclymphocyticleukemiapatientstreatedwithibrutinibinalbania20182022 |